Complete remission of keratosis lichenoides chronica with abrocitinib

Dermatology Reports · Published 2026-06-08 · DOI 10.4081/dr.2026.10666

Free full text

Authors (8)

Caterina Mariarosaria Giorgio, Anna Balato, Giuseppe Argenziano, Paolino Franzese, Elisabetta Fulgione, Mariateresa Cantelli, Maria Maddalena Nicoletti, Gaetano Licata

Abstract

Dear Editor, Keratosis lichenoides chronica (KLC), also known as Nekam’s disease, is a rare and recalcitrant lichenoid dermatosis. It manifests with keratotic violaceous papules arranged in linear or reticulated patterns and typically follows a chronic and disabling course. Therapeutic guidelines are lacking, and conventional treatments – including corticosteroids, retinoids, immunosuppressants, and phototherapy – often fail to provide sustained benefit. Given its rarity, each therapeutic observation carries significant relevance. [...]

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year
2026

Citation

Giorgio, C., Balato, A., Argenziano, G., et al. (2026). Complete remission of keratosis lichenoides chronica with abrocitinib. Dermatology Reports. https://doi.org/10.4081/dr.2026.10666

Related articles